MedTrace Logo

Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors

NCT03967379 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-02-04

Study results available
· View outcomes & findings →

Summary

This research study is being done to evaluate whether the use of a mobile app can help transplant survivors experiencing sexual health problems.

Conditions

  • Other Cancer

Interventions

BEHAVIORAL

Mobile App + enhanced standard care

An intervention to help address sexual dysfunction among HCT survivors

OTHER

Enhanced Standard Care

Standard of care administered by the institution

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Areej El-Jawahri, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2023-01-01
Completion
2024-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967379 on ClinicalTrials.gov